Stable isotope studies show differences in effect of insulin detemir and NPH insulin on hepatic glucose output and peripheral glucose uptake after subcutaneous administration in subjects with type1 diabetes

被引：0
|
作者：
Hordern, VM
Wright, JE
Umpleby, M
Jacobsen, L
Draeger, E
Russell-Jones, DL
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1187
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [31] Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes
    Chase, HP
    Saib, SZ
    MacKenzie, T
    Hansen, MM
    Garg, SK
    [J]. DIABETIC MEDICINE, 2002, 19 (04) : 317 - 321
  • [32] Evidence for spatial heterogeneity in insulin- and exercise induced increases in glucose uptake.: Studies in normal subjects and patients with type 1 diabetes
    Knuuti, J
    Peltoniemi, P
    Yki-Järvinen, H
    Laine, H
    Oikonen, V
    Rönnemaa, T
    Kalliokoski, K
    Raitakari, O
    Nuutila, P
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1005 - 1005
  • [33] Evidence for spatial heterogeneity in insulin-and exercise-induced increases in glucose uptake:: Studies in normal subjects and patients with type 1 diabetes
    Peltoniemi, P
    Yki-Järvinen, H
    Laine, H
    Oikonen, V
    Rönnemaa, T
    Kalliokoski, K
    Raitakari, O
    Knuuti, MJ
    Nuutila, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11): : 5525 - 5533
  • [34] Insulin degludec/insulin aspart produces a dose-proportional glucose-lowering effect in subjects with type 1 diabetes mellitus
    Heise, T.
    Nosek, L.
    Klein, O.
    Coester, H.
    Svendsen, A. L.
    Haahr, H.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (07): : 659 - 664
  • [35] INSULIN DEGLUDEC/INSULIN ASPART (IDEGASP) PRODUCES A DOSE-PROPORTIONAL GLUCOSE-LOWERING EFFECT IN SUBJECTS WITH TYPE 1 DIABETES
    Heise, T.
    Nosek, L.
    Coester, H.
    Klein, O.
    Roepstorff, C.
    Svendsen, A. L.
    Haahr, H.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S173 - S174
  • [36] Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
    Rodbard, David
    Jovanovic, Lois
    Garg, Satish K.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (12) : 757 - 765
  • [37] Cerebral Blood Flow and Glucose Metabolism in Appetite-Related Brain Regions in Type 1 Diabetic Patients After Treatment With Insulin Detemir and NPH Insulin A randomized controlled crossover trial
    van Golen, Larissa W.
    IJzerman, Richard G.
    Huisman, Marc C.
    Hensbergen, Jolanda F.
    Hoogma, Roel P.
    Drent, Madeleine L.
    Lammertsma, Adriaan A.
    Diamant, Michaela
    [J]. DIABETES CARE, 2013, 36 (12) : 4050 - 4056
  • [38] Insulin detemir achieves lower, less variable fasting glucose and a reduced risk of nocturnal hypoglycaemia and weight gain compared to NPH insulin in basal bolus therapy of Japanese patients with type 1 diabetes
    Kobayashi, M.
    Iwamoto, Y.
    Kawamori, R.
    Tajima, N.
    Nishida, T.
    Kaku, K.
    [J]. DIABETOLOGIA, 2006, 49 : 608 - 609
  • [39] RANDOMIZED CLINICAL-TRIAL OF THE EFFECT OF GLUCOSE CONTROL FROM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ON PERIPHERAL-NERVE FUNCTION IN TYPE-1 (INSULIN-DEPENDENT) DIABETES
    SERVICE, FJ
    DYCK, PJ
    DAUBE, JR
    OBRIEN, PC
    HALL, LD
    WESTLAND, RE
    RIZZA, RA
    [J]. DIABETOLOGIA, 1983, 25 (02) : 194 - 194
  • [40] Decreased Hepatic HMGB1 in Type 2 Diabetes Increases Mitochondrial Glucose Uptake by Regulating Insulin/AKT Signaling
    Liu, Zeyu
    Kaltenmeier, Christof
    Alvidrez, Roberto I. Mota
    [J]. DIABETES, 2022, 71
12345